Bottom line
IRCYX vs IEFA: the short answer
IRCYX (International Small Cap Portfolio) and IEFA (iShares Core MSCI EAFE ETF) are both mutual funds.
But IEFA is far broader, holding 2,632 positions to 381 for IRCYX, so beyond the top names it adds exposure IRCYX doesn't have.
IEFA is cheaper at 0.07% vs 1.09% — a difference of $102 a year per $10,000 invested.
Over five years, IRCYX returned +7.9% a year vs +4.5% for IEFA (reporting dates differ).
Updated Nov 19, 2026
IRCYX vs IEFA side by side
| IRCYX | IEFA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Bernstein | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 1.09% | 0.07% |
| Annual cost per $10k | $109 | $7 |
| 10-yr cost on $10k (prospectus) | $1,329 | $90 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +34.9% | +3.4% |
| 5-yr return (annualized) | +7.9% | +4.5% |
| 10-yr return (annualized) | +7.8% | +5.4% |
| Best quarter | — | +18.0% |
| Worst quarter | — | −23.5% |
| Net assets (fund) | $1.3B | $190.1B |
| Number of holdings | 381 | 2,632 |
| Portfolio turnover | 57% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
IRCYX and IEFA share none of their top holdings.
IRCYX top 10
- Alliance Bernstein — 3.34%
- Balfour Beatty PLC — 1.84%
- Elite Material Co Ltd — 1.81%
- Nanya Technology Corp — 1.34%
- Acter Group Corp Ltd — 1.31%
- Alpha Bank SA — 1.16%
- Capital Power Corp — 1.13%
- Nexans SA — 1.11%
- Lundin Mining Corp — 1.00%
- Hiscox Ltd — 0.95%
IEFA top 10
- ASML Holding N.V. — 2.50%
- Hsbc Holdings Plc — 1.42%
- Roche Holding AG — 1.20%
- Novartis AG — 1.12%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
- Nestle S.A. — 1.00%
- Astrazeneca Plc — 1.00%
- Shell Plc — 1.00%
- Siemens Aktiengesellschaft — 0.95%
- Mitsubishi UFJ Financial Group, Inc. — 0.93%
FAQ
What is the difference between IRCYX and IEFA?
Which is cheaper, IRCYX or IEFA?
Should I own both IRCYX and IEFA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.